Phase 1 study of BBT-015 in healthy human subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Aug 2017
At a glance
- Drugs BBT-015 (Primary)
- Indications Acute radiation syndrome; Neutropenia
- Focus Adverse reactions; Pharmacokinetics
- 08 Aug 2017 New trial record
- 02 Aug 2017 According to a Bolder BioTechnology media release, dosing of patients has been initiated.